6 Pharmaceuticals Stocks to Sell Now

6 Pharmaceuticals Stocks to Sell Now

The ratings of 6 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

Bristol-Myers Squibb Company (BMY) is having a tough week. The company’s rating falls from a C to a D. Bristol-Myers Squibb Company is a global company that develops, produces and sells pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of BMY stock.

Collegium Pharmaceutical, Inc. (COLL) declines this week from a C to a D. The company also gets F’s in earnings revisions, earnings surprise, earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of COLL stock.

Slipping from a D to a F rating, Akari Therapeutics Plc Sponsored ADR (AKTX) takes a hit this week. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of AKTX stock.

Oculus Innovative Sciences, Inc. (OCLS) experiences a ratings drop this week, going from last week’s D to a F. Oculus Innovative Sciences, Inc. develops and manufactures products to prevent and eliminate infections in chronic and acute wounds. The company also gets F’s in earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of OCLS stock.

Tetraphase Pharmaceuticals, Inc.’s (TTPH) rating weakens this week, dropping to a F versus last week’s D. The company also gets F’s in sales growth, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of TTPH stock.

Novogen Limited Sponsored ADR (NVGN) gets weaker ratings this week as last week’s C drops to a D. Novogen Limited Sponsored ADR is a medical services company which develops and markets pharmaceutical products in Australia. For more information, get Portfolio Grader’s complete analysis of NVGN stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/09/6-pharmaceuticals-stocks-to-sell-now-7/.

©2019 InvestorPlace Media, LLC